Literature DB >> 15814604

TolC but not AcrB is essential for multidrug-resistant Salmonella enterica serotype Typhimurium colonization of chicks.

Sylvie Baucheron1, Christian Mouline, Karine Praud, Elisabeth Chaslus-Dancla, Axel Cloeckaert.   

Abstract

OBJECTIVES: To study the role of the multidrug efflux system AcrAB-TolC in resistance of multidrug-resistant Salmonella enterica serotype Typhimurium (S. Typhimurium) phage type DT104 and DT204 strains to detergents and bile salts. To evaluate the importance of the inner membrane transporter AcrB and the outer membrane component TolC of this efflux system in the colonization of two multidrug-resistant S. Typhimurium DT104 and one DT204 strain in chicks.
METHODS: acrB and tolC mutants of multidrug-resistant S. Typhimurium DT104 and DT204 strains were constructed by insertional inactivation of the acrB gene and deletion of the tolC gene. MICs of detergent and bile salts were determined for the wild-type strains, the acrB and the tolC mutant strains, in presence and in absence of the efflux pump inhibitor Phe-Arg beta-naphthylamide. The effect of sodium choleate on the in vitro growth of these strains was also evaluated. The LD50s of the strains were measured in a day-old chicken model, inoculated with several doses (1 x 10(3) to 1 x 10(8) cfu) by the oral route, for 7 days post-inoculation. The colonization levels were assessed at the sublethal dose 7 days post-inoculation by determining the number of cfu of Salmonella in the faeces, caecum, spleen and liver.
RESULTS: The decrease in resistance levels to bile salts was 64- to 256-fold higher for the tolC mutants than for the acrB mutants relative to those of the parental strains. Addition of choleate in culture medium did not affect the growth of the wild-type strains or that of the acrB mutants, but inhibited completely the growth of the tolC mutants. The LD50s were 1.0 x 10(6) and 1.2 x 10(7) cfu for one wild-type S. Typhimurium DT104 strain and the acrB mutant, respectively, and were >1.0 x 10(8) for the tolC mutants or the S. Typhimurium DT204 strains. In contrast to the acrB mutants, the tolC mutants were unable to colonize the caecum, spleen and liver after 1 week of infection. Moreover, in most chicks, no intestinal excretion was detected for the tolC mutants. The colonization levels of the acrB mutants were not significantly different from those of the wild-type strains.
CONCLUSIONS: TolC but not AcrB appears to be essential for multidrug-resistant S. Typhimurium DT104 and DT204 colonization of chicks, which is in accordance with their respective roles in resistance to detergents and bile salts. Therefore, TolC could be a better target than AcrB for the development of efflux pump inhibitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814604     DOI: 10.1093/jac/dki091

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  21 in total

1.  TdeA, a TolC-like protein required for toxin and drug export in Aggregatibacter (Actinobacillus) actinomycetemcomitans.

Authors:  Juan A Crosby; Scott C Kachlany
Journal:  Gene       Date:  2006-10-17       Impact factor: 3.688

Review 2.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

3.  Transcriptional activation by MarA, SoxS and Rob of two tolC promoters using one binding site: a complex promoter configuration for tolC in Escherichia coli.

Authors:  Aixia Zhang; Judah L Rosner; Robert G Martin
Journal:  Mol Microbiol       Date:  2008-07-31       Impact factor: 3.501

Review 4.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

5.  RamA, a member of the AraC/XylS family, influences both virulence and efflux in Salmonella enterica serovar Typhimurium.

Authors:  Andrew M Bailey; Al Ivens; Rob Kingsley; Jennifer L Cottell; John Wain; Laura J V Piddock
Journal:  J Bacteriol       Date:  2010-01-15       Impact factor: 3.490

6.  Exploiting the role of TolC in pathogenicity: identification of a bacteriophage for eradication of Salmonella serovars from poultry.

Authors:  Vito Ricci; Laura J V Piddock
Journal:  Appl Environ Microbiol       Date:  2010-01-15       Impact factor: 4.792

7.  RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.

Authors:  Andrew M Bailey; Ian T Paulsen; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

8.  Identification of the enzyme responsible for N-acetylation of norfloxacin by Microbacterium sp. Strain 4N2-2.

Authors:  Dae-Wi Kim; Jinhui Feng; Huizhong Chen; Ohgew Kweon; Yuan Gao; Li-Rong Yu; Vanessa J Burrowes; John B Sutherland
Journal:  Appl Environ Microbiol       Date:  2012-10-26       Impact factor: 4.792

9.  The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host.

Authors:  Mark A Webber; Andrew M Bailey; Jessica M A Blair; Eirwen Morgan; Mark P Stevens; Jay C D Hinton; Al Ivens; John Wain; Laura J V Piddock
Journal:  J Bacteriol       Date:  2009-05-01       Impact factor: 3.490

10.  Genetic exchange of multidrug efflux pumps among two enterobacterial species with distinctive ecological Niches.

Authors:  Nehaya Al-Karablieh; Helge Weingart; Matthias S Ullrich
Journal:  Int J Mol Sci       Date:  2009-02-19       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.